In another study involving co-delivery of agonists, concurrent targeting of TLRs 7, 8, and 9 by intratumoural injection increased the number and tumouricidal activity of tumour infiltrating CD8+ T cells and NK cells, and reduced the frequency of immunosuppressive MDSCs [48]. This evidence concerns the gene CD8A and neoplasm.